Adult Immunization

Latest News

Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial / image credit Moderna logo: ©desertsands/stock.adobe.com
Moderna Next-Gen mRNA COVID-19 Vaccine Meets Primary Endpoints in NextCOVE Phase 3 Trial

March 27th 2024

The mRNA bivalent vaccine candidate produced a "more robust" immune response vs Spikevax and particularly in adults over the age of 65 years, said Moderna.

Respiratory virus vaccines on deck for 2024 /image credit vaccine vials: ©Mr.Ilkin/stock.adobe.com
Respiratory Virus Vaccines on Deck for 2024

March 22nd 2024

Long COVID's Long Road/ image credit road to distance: ©Rawpixel.com/stock.adobe.com
Long COVID's Long Road: The Muddled Map at 4 Years

March 21st 2024

©Kateryna_Kon/stock.adobe.com
Merck's 21-Valent Adult-Specific Pneumococcal Vaccine Accrues New Phase 3 and Real World Data

March 19th 2024

Abrysvo Efficacy Sustained in Older Adults Through Second RSV Season /image credit Pfizer logo: ©Kathy Images stock.adobe.com
Abrysvo Efficacy Sustained in Older Adults Through Second RSV Season

March 1st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.